Drug Profile
Methadone sublingual - LondonPharma
Latest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator LondonPharma
- Class Drug withdrawal therapies; Ketones; Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer pain; Opioid-related disorders
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Cancer-pain in United Kingdom (Sublingual, Spray)
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Opioid-abuse in United Kingdom (Sublingual, Spray)